188 related articles for article (PubMed ID: 37655327)
21. A simple self-adjuvanting biomimetic nanovaccine self-assembled with the conjugate of phospholipids and nucleotides can induce a strong cancer immunotherapeutic effect.
Liu D; Liu J; Ma B; Deng B; Leng X; Kong D; Liu L
Biomater Sci; 2021 Jan; 9(1):84-92. PubMed ID: 33016303
[TBL] [Abstract][Full Text] [Related]
22. Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy.
Qian Y; Jin H; Qiao S; Dai Y; Huang C; Lu L; Luo Q; Zhang Z
Biomaterials; 2016 Aug; 98():171-83. PubMed ID: 27192420
[TBL] [Abstract][Full Text] [Related]
23. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
[TBL] [Abstract][Full Text] [Related]
24. Synthetic Polymeric Mixed Micelles Targeting Lymph Nodes Trigger Enhanced Cellular and Humoral Immune Responses.
Li C; Zhang X; Chen Q; Zhang J; Li W; Hu H; Zhao X; Qiao M; Chen D
ACS Appl Mater Interfaces; 2018 Jan; 10(3):2874-2889. PubMed ID: 29285934
[TBL] [Abstract][Full Text] [Related]
25. Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses.
Wang N; Zuo Y; Wu S; Huang C; Zhang L; Zhu D
Acta Pharm Sin B; 2022 Dec; 12(12):4486-4500. PubMed ID: 36561992
[TBL] [Abstract][Full Text] [Related]
26. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.
Zhang C; Shi G; Zhang J; Song H; Niu J; Shi S; Huang P; Wang Y; Wang W; Li C; Kong D
J Control Release; 2017 Jun; 256():170-181. PubMed ID: 28414151
[TBL] [Abstract][Full Text] [Related]
27. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929
[TBL] [Abstract][Full Text] [Related]
28. Elastic Nanovaccine Enhances Dendritic Cell-Mediated Tumor Immunotherapy.
Li Q; Teng Z; Tao J; Shi W; Yang G; Zhang Y; Su X; Chen L; Xiu W; Yuwen L; Dong H; Mou Y
Small; 2022 Aug; 18(32):e2201108. PubMed ID: 35734820
[TBL] [Abstract][Full Text] [Related]
29. Metal-Phenolic Network-Encapsulated Nanovaccine with pH and Reduction Dual Responsiveness for Enhanced Cancer Immunotherapy.
Zhou X; Su Q; Zhao H; Cao X; Yang Y; Xue W
Mol Pharm; 2020 Dec; 17(12):4603-4615. PubMed ID: 33175556
[TBL] [Abstract][Full Text] [Related]
30. A biotin-avidin-system-based virus-mimicking nanovaccine for tumor immunotherapy.
Lu Z; Zhang Y; Wang Y; Tan GH; Huang FY; Cao R; He N; Zhang L
J Control Release; 2021 Apr; 332():245-259. PubMed ID: 33647430
[TBL] [Abstract][Full Text] [Related]
31. Hollow metal-organic framework-based, stimulator of interferon genes pathway-activating nanovaccines for tumor immunotherapy.
Zhao Y; Song R; Zhang Z; Hu H; Ning W; Duan X; Jiao J; Fu X; Zhang G
Nanoscale Adv; 2023 Dec; 6(1):72-78. PubMed ID: 38125595
[TBL] [Abstract][Full Text] [Related]
32. Direct Presentation of Tumor-Associated Antigens to Induce Adaptive Immunity by Personalized Dendritic Cell-Mimicking Nanovaccines.
Zhang J; Fan B; Cao G; Huang W; Jia F; Nie G; Wang H
Adv Mater; 2022 Nov; 34(47):e2205950. PubMed ID: 36217832
[TBL] [Abstract][Full Text] [Related]
33. In Vivo Imaging Tracking and Immune Responses to Nanovaccines Involving Combined Antigen Nanoparticles with a Programmed Delivery.
Dong X; Liang J; Yang A; Wang C; Kong D; Lv F
ACS Appl Mater Interfaces; 2018 Jul; 10(26):21861-21875. PubMed ID: 29901978
[TBL] [Abstract][Full Text] [Related]
34. Dendritic Cell-Targeted Nanovaccine Delivery System Prepared with an Immune-Active Polymer.
Rajput MKS; Kesharwani SS; Kumar S; Muley P; Narisetty S; Tummala H
ACS Appl Mater Interfaces; 2018 Aug; 10(33):27589-27602. PubMed ID: 30048112
[TBL] [Abstract][Full Text] [Related]
35. A novel self-assembled epitope peptide nanoemulsion vaccine targeting nasal mucosal epithelial cell for reinvigorating CD8
Yang Y; Ge S; Song Z; Zhao A; Zhao L; Hu Z; Cai D; Zhang Z; Peng L; Lu D; Luo P; Zhang W; Sun H; Zou Q; Zeng H
Int J Biol Macromol; 2021 Jul; 183():1891-1902. PubMed ID: 34052270
[TBL] [Abstract][Full Text] [Related]
36. Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo.
Lu Y; Liu ZH; Li YX; Xu HL; Fang WH; He F
Int J Nanomedicine; 2022; 17():1593-1608. PubMed ID: 35411142
[TBL] [Abstract][Full Text] [Related]
37. Mimetic Heat Shock Protein Mediated Immune Process to Enhance Cancer Immunotherapy.
Li X; Cai X; Zhang Z; Ding Y; Ma R; Huang F; Liu Y; Liu J; Shi L
Nano Lett; 2020 Jun; 20(6):4454-4463. PubMed ID: 32401534
[TBL] [Abstract][Full Text] [Related]
38. Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase.
Guan X; Chen J; Hu Y; Lin L; Sun P; Tian H; Chen X
Biomaterials; 2018 Jul; 171():198-206. PubMed ID: 29698869
[TBL] [Abstract][Full Text] [Related]
39. Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8
Darling R; Senapati S; Christiansen J; Liu L; Ramer-Tait AE; Narasimhan B; Wannemuehler M
Int J Nanomedicine; 2020; 15():6579-6592. PubMed ID: 32982219
[TBL] [Abstract][Full Text] [Related]
40. Endolysosomal-Escape Nanovaccines through Adjuvant-Induced Tumor Antigen Assembly for Enhanced Effector CD8
Qiu L; Valente M; Dolen Y; Jäger E; Beest MT; Zheng L; Figdor CG; Verdoes M
Small; 2018 Apr; 14(15):e1703539. PubMed ID: 29493121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
